16/02/2017 |
CENTAURO-6 Study |
CIGB |
Registered |
27/04/2017 |
Hepatotoxicity by drugs |
CenQfal |
Registered |
03/05/2020 |
Pharmacodynamics of the Nasalferon in healthy volunteers. |
CIGB |
Registered |
30/04/2017 |
Nimotuzumab-pancreatic cancer-adults-Phase IV. |
CIM |
Registered |
30/04/2017 |
HEBERBIOVAC HB vaccine to reference material. |
CIGB |
Registered |
29/09/2017 |
Safety and effectiveness of SURFACEN® combined with the conventional therapy, in the treatment of ARDS in pediatrics. National extension |
CENSA |
Registered |
17/04/2018 |
Obex® - Overweight and Obese - Adults - Phase III |
CATALYSIS |
Registered |
17/04/2018 |
Biomarkers of exposition_Uchuva Dorada |
kmunoz |
Registered |
10/05/2018 |
Oncoxin-Viusid/Stomach and gastric esophagus union cancer / Adults / Phase II |
CATALYSIS |
Registered |
05/10/2018 |
Nimotuzumab cold kit for the immunodiagnosis of solid tumors |
CIM |
Registered |
03/08/2018 |
CIMAvax-EGF-Platelets-Adults- Lung Cancer |
CIM |
Registered |
30/05/2018 |
Treatment for maxillary cysts |
SSA |
Registered |
17/10/2018 |
CIMAvax-EGF® in metastatic asymptomatic or mildly symptomatic Castration Resistant Prostate Cancer patients. Phase II-III Clinical Trial |
CIM |
Registered |
18/05/2018 |
Gastricel-I |
CIDEM |
Registered |
08/08/2018 |
VSSP in metastasic renal cell carcinoma |
CIM |
Registered |
12/03/2019 |
A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer |
ROCHE |
Registered |
09/07/2018 |
Racotumomab vaccine- Lung Cancer- Adults-predictors of response - Exploratory |
CIM |
Registered |
11/06/2018 |
Usual treatment plus intra-articular application of bioactive formulation for osteoarthritis |
SSA |
Registered |
02/08/2018 |
NeuroEPO in stroke |
CIM |
Registered |
01/11/2018 |
Effectiveness of a case management model for the comprehensive provision of health services to pluripathological patients |
FUCS |
Registered |